Cost-effectiveness of testing and treatment for latent tuberculosis infection in residents born outside the United States with and without medical comorbidities in a simulation model | HCV Guidance

HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C

Cost-effectiveness of testing and treatment for latent tuberculosis infection in residents born outside the United States with and without medical comorbidities in a simulation model

Tasillo A, Salomon JA, Trikalinos TA, Horsburgh, Jr CR, Marks SM, Linas BP. Cost-effectiveness of testing and treatment for latent tuberculosis infection in residents born outside the United States with and without medical comorbidities in a simulation model. JAMA Intern Med. 2017;177(12):1755-1764.

Publication Type:

Journal Article

Authors:

Tasillo, A; Salomon, JA; Trikalinos, TA; Horsburgh, CR Jr; Marks, SM; Linas, BP

Source:

JAMA Intern Med, Volume 177, Issue 12, p.1755-1764 (2017)

Cited On:

Key Populations: Identification and Management of HCV in People Who Inject Drugs

Export Citation:

RIS Format

Top